FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/03/012530 [Registered on: 13/03/2018] Trial Registered Prospectively
Last Modified On: 13/03/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Process of Care Changes 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Whether herbal eye drops help in management of dry eye syndrome ? 
Scientific Title of Study   "Role of Rajnidaaru eye drops and Rasayan Churna in the management of Shushkaakshipaka (Dry eye syndrome) - An open label double arm randomized clinical trial” 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neeraj Dubey 
Designation  P.G. Scholor 
Affiliation  All india institue of ayurveda 
Address  OPD No-101 1 st floor, Hospital Block ,All India Institute of Ayurveda
Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi
South West
DELHI
110076
India 
Phone    
Fax    
Email  dubenrj@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neeraj Dubey 
Designation  P.G. Scholor 
Affiliation  All india institue of ayurveda 
Address  OPD No-101 1 st floor, Hospital Block ,All India Institute of Ayurveda
Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi
South West
DELHI
110065
India 
Phone  8285520530  
Fax    
Email  dubenrj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Neeraj Dubey 
Designation  P.G. Scholor 
Affiliation  All india institue of ayurveda 
Address  OPD No-101 1 st floor, Hospital Block ,All India Institute of Ayurveda
Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi
South West
DELHI
110065
India 
Phone  8285520530  
Fax    
Email  dubenrj@gmail.com  
 
Source of Monetary or Material Support  
All India institute of Ayurveda,Gautampuri,Sarita Vihar,New Delhi-110076 
 
Primary Sponsor  
Name  All india Institute of Ayurveda 
Address  Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manjusha Rajagopala  AIIA  OPD No-101,Department of Shalakya Tantra,All India Institute of AyurvedaGautampuri,Sarita Vihar,New Delhi-110076
South West
DELHI 
7600901848

bhatrajma2008@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients with sign and symptoms of shuskakshipaaka (dry eye syndrome),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Rajnidaaru Eyedrop  2 drops in both eyes will be administered twice a day for 42 days. 
Comparator Agent  Rajnidaaru eyedrop with Rasayan Churna  2 drops in both eyes will be administered twice a day for 42 days along with 3g Rasayan Churna twice a day for 42 day 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients of either sex aged up to18 - 60 years.
2.Patients presenting with signs and symptoms of Dry eye syndrome.
3.Willing and able to participate in the study.
 
 
ExclusionCriteria 
Details  1.Age group less than 18 and more than 60 years.
2.Severe cases of dry eye syndrome with complications like perforated corneal ulcer, Uveitis, Glaucoma.
3.Allergic eye disease i.e. vernal keratoconjunctivitis, Giant papillary conjunctivitis.
4.Non specific topical beta blocker users.
5.Inflammatory conditions like acute conjunctivitis.
6.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study.
7.Patients suffering from major systemic illness necessitating long term drug treatment i.e. Psycho-epileptic drug users.
8.H/o hypersensitivity to the trial drug or any of its ingredients.
9.Persistent Contact Lens Users. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in clinical features of dry eye syndrome  The patients will be assesed at the end of the study 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in the quality of life  The patients will be assesed at the end of the study 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/04/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="2"
Days="3" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   The outcomes of the study will be communicated to peer reviewed journals. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is an open label double arm randomised clinical trial comparing the efficacy of Rajnidaaru eye drops (2drop in each eye)along with Rasayan Churna(3g BD) and alone for 42 days in patients of shuskakshipaaka (Dry eye syndrome) for 30 days.The trail will be conducted in All India institute of Ayurveda.The primary outcome measures will be reduction in th clinical features of dry eye syndrome and the secondary outcomes will be changes in quality of life. 
Close